Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christian Gille has a total of 130 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany—2026 Update

    by Maximilian David Mauritz, Ulrich von Both, Christian Dohna-Schwake, Christian Gille, Johannes Huebner, Markus Hufnagel, Johannes G. Liese, Hanna Renk, Henriette Rudolph, Ulf Schulze-Sturm, et al.

    Children and adolescents with severe neurological impairment (SNI) require specialized care due to their complex medical needs. These patients often experience severe, recurrent lower respiratory tract infections (LRTIs). These infections, of both viral and bacterial etiology, pose a significant risk to these patients, often resulting in respiratory insufficiency and long-term impairments. Based on expert consensus and newly available data, we have updated the previous 2024 clinical recommendations on the management of LRTIs in children and adolescents with SNI in Germany. This update now also addresses multidrug-resistant organism colonization, respiratory support, discharge planning, and prophylactic strategies. The recommendations emphasize comprehensive multidisciplinary care, antimicrobial stewardship, and a stepwise, risk-stratified approach to antibiotic therapy. Initial treatment should involve symptomatic care, including hydration, antipyretics, oxygen therapy, secretion management, and respiratory as well as cough support. In suspected bacterial LRTIs, antibiotic treatment (ABT) should be guided by clinical severity, previous microbiological findings, and treatment response, with an aminopenicillin plus a beta-lactamase inhibitor recommended for community-acquired LRTIs and piperacillin-tazobactam reserved for selected high-risk patients. Ongoing management includes regular reassessment, adjustment of ABT based on pathogen identification, and optimization of supportive care. Conclusion : The updated recommendations provide a practical, multidisciplinary framework for the inpatient management of LRTIs in children and adolescents with SNI, combining optimized supportive care with antimicrobial stewardship and a stepwise, risk-stratified approach to antibiotic treatment. What is Known: • Children and adolescents with severe neurological impairment are particularly affected by severe and recurrent lower respiratory tract infections (LRTI) • The indication and choice of antibiotic therapy for bacterial LRTI is often difficult because there are no evidence-based treatment recommendations for this heterogeneous but vulnerable patient population • The frequent overuse of broad-spectrum or reserve antibiotics in this patient population increases selection pressure for multidrug-resistant pathogens What is New: • Compared with the 2024 recommendations, this update provides more detailed guidance on secretion management and respiratory and cough support, introduces explicit discharge criteria, and expands decision-making for patients colonized with multidrug-resistant organisms. The antibiotic strategy has been further specified regarding broad-spectrum antibiotic therapy, while preventive recommendations have been expanded and updated.

  • Open Access

    Delayed Admission to NICU Is Associated With In‐Hospital Mortality After Perinatal Asphyxia: A Retrospective Single‐Centre Study

    by Simon A. Kranig, Navina Kuß, Ricarda Will, Natascha Köstlin‐Gille, Christoph E. Schwarz, Christian Gille

    Aim: To investigate whether outborn birth, defined as birth in a maternity unit without permanent in‐house paediatric coverage and the need for postnatal transfer, is associated with in‐hospital mortality in infants with perinatal asphyxia treated with therapeutic hypothermia, compared to birth at a tertiary cooling centre. Methods: Retrospective single‐centre cohort study of infants ≥ 36 weeks of gestation with perinatal asphyxia receiving therapeutic hypothermia at a German tertiary centre serving nine maternity units, between 1 January 2012 and 31 January 2025. Results: Of 5541 infants admitted, 131 (2.4%) were treated for perinatal asphyxia, of whom 82/131 (62.6%) received therapeutic hypothermia with an in‐hospital mortality of 21/82 (25.6%). Mortality was 2/25 (8.0%) in inborn and 19/57 (33.3%) in outborn infants (odds ratio 5.8, 95% confidence interval 1.3–26.4). Among outborn infants, mortality was higher after birth in rural than in urban units (16/33 (48.5%) versus 3/24 (12.5%); odds ratio 6.6, 95% confidence interval 1.6–23.4). Non‐survivors waited longer for the arrival of the neonatal team (mean 38 vs. 28 min). Mortality was comparable between inborn infants and outborn infants born in urban units. Conclusion: Outborn birth, particularly in rural maternity units with longer times to specialised neonatal care, was associated with in‐hospital mortality.

  • Open Access

    LPS and β-Glucan Induce Differential Memory-like Inflammatory Responses with Enhanced Reactivity in Neonatal Neutrophils Compared to Adults

    by Lisa Zagler, Laura Snaidr, Natascha Köstlin-Gille, Heidi Hildenbrand, Nadja Kliegel, David L. Williams, Ricarda Will, Stefanie Dietz-Ziegler, Cahit Birdir, Christian Gille, et al.

    Neutrophils are key effectors of innate immunity. Although traditionally regarded as short-lived effector cells, recent evidence suggests they can undergo functional reprogramming after microbial stimulation, leading to trained immunity. We investigated whether lipopolysaccharide (LPS) or Candida albicans β-glucan induces memory-like inflammatory responses in adult peripheral and neonatal cord blood neutrophils. We used complementary molecular and functional approaches to characterize neutrophil responses following in vitro priming with LPS or β-glucan and subsequent LPS restimulation. Cytokine secretion, reactive oxygen species (ROS) production, glycolytic activity (via lactate production and glycolytic enzyme expression), and ERK1/2 and NF-κB signaling pathway activation were assessed. Priming with LPS or β-glucan enhanced neutrophil responsiveness to secondary stimulation, resulting in increased secretion of IL-1β, IL-6, IL-8, CXCL1, and CCL2, together with elevated ROS production. These effects were consistently more pronounced in neonatal than in adult neutrophils. Memory-like neutrophils also exhibited metabolic reprogramming, associated by increased hexokinase-2 and phosphofructokinase-1 mRNA expression, elevated lactate production, and enhanced ERK1/2 and NF-κB activation. Human neutrophils, particularly neonatal cells, develop memory-like characteristics following LPS or β-glucan priming, highlighting their functional and metabolic plasticity and suggesting a role for neutrophil training in early-life immune adaptation.

  • Open Access

    Neonatal monocyte iron metabolism and immunometabolic responses in sepsis: a comparative ex vivo investigation

    by Soumya Lutterbach, Christina Mertens, Trim Lajqi, Judith Schenz, Eva Schöndorf-Holland, Markus A. Weigand, Martina U. Muckenthaler, Christian Gille, Dania Fischer

    Background: Neonatal sepsis is a leading cause of morbidity and mortality in neonates. The underdeveloped neonatal immune system, particularly innate immune cells such as monocytes, plays a critical role in susceptibility to infection. Monocyte-mediated regulation of iron metabolism, a key component of “nutritional immunity,” is known to influence sepsis outcomes in adults. In this study, we investigated differences in iron sensing, iron-regulated gene expression, and intracellular iron content between neonatal and adult monocytes. Methods: Monocytes were isolated from human umbilical cord blood and adult peripheral blood and stimulated in vitro with lipopolysaccharide (LPS), ferric nitrilotriacetate (FeNTA), or the iron chelator deferoxamine (DFO). Transferrin receptor 1 (TfR1) and differentiation markers were analyzed by flow cytometry, intracellular iron content by atomic absorption spectrometry, and metabolic and inflammatory responses via lactate and cytokine measurements. Results: Neonatal monocytes exhibited lower basal TfR1 expression with a trend toward higher intracellular iron. LPS induced TfR1 upregulation exclusively in adult monocytes, while neonatal cells maintained consistently low expression. Although FeNTA increased intracellular iron in both groups, neonatal monocytes accumulated iron less efficiently. Conclusion: These findings indicate fundamental developmental differences in monocyte iron handling and immunometabolic adaptation, which may underlie the distinct immune profile observed in neonatal sepsis. Impact: Neonatal sepsis is a leading cause of morbidity and mortality in neonates. Particularly innate immune cells such as monocytes, play a critical role in susceptibility to infection. Monocyte-mediated regulation of iron metabolism, a key component of “nutritional immunity,” is known to influence sepsis outcomes in adults. Our findings indicate fundamental developmental differences in monocyte iron handling and immunometabolic adaptation, which may play a role in both the distinct immune profile observed in neonatal sepsis and, consecutively, sepsis outcome. These findings imply that host-directed iron modulation could be a viable strategy to counteract immunoparalysis in neonatal sepsis without compromising cellular activation.

  • Open Access

    Urinary Metabolomics Predict Acute Kidney Injury in Very-Low-Birth-Weight Infants with Patent Ductus Arteriosus

    by Moritz Niesert, Claire Cannet, Alexander Fichtner, Georg F. Hoffmann, Jürgen G. Okun, Dóra Pituk, Christian Gille, Johannes Pöschl, Sina Waldherr, Andreas Ziegler, et al.

    Very preterm infants with immature kidneys exhibit high vulnerability to acute kidney injury (AKI). While AKI is associated with adverse outcomes, serum-creatinine-based diagnostics prove unreliable in early risk assessment of kidney damage. This pilot study investigated 1H-NMR spectroscopy-based metabolomics for the identification of very-low-birth-weight (VLBW < 1500 g) infants at risk of AKI before and during indomethacin treatment for patent ductus arteriosus (PDA). Longitudinal urine samples (0 h, 12 h, 36 h, 84 h, 120 h, 14 d, 28 d) from 12 VLBW infants receiving indomethacin for hemodynamically significant PDA were analyzed by 1H-NMR spectroscopy. In total, 150 urinary metabolites were annotated and single-metabolite and multivariate analyses were performed. At 36 h after treatment initiation, three patients (25%) developed AKI (KDIGO criteria). Principal component analysis (PCA) revealed significant differences in urinary metabolic profiles between the AKI and non-AKI groups 12 h after indomethacin initiation. Before treatment, five metabolites were significantly lower in the AKI group: adenine, creatine, dimethylglycine, 1-methylnicotinamide, and methylmalonic acid. Urinary creatine/creatinine (AUC 0.97) and 1-methylnicotinamide/creatinine (AUC 0.93) exhibited promising prognostic accuracy for the prediction of AKI. 1-methylnicotinamide/creatinine concentrations remained persistently reduced during the study. In conclusion, urinary metabolomics, particularly creatine and 1-methylnicotinamide levels, may serve as valuable non-invasive biomarkers for identifying VLBW infants at risk of AKI.


  • Erkrankungen des Zentralnervensystems

    by Christoph Fusch, Nicole Heußinger, Christian Gille, Claudia Roll, Katrin Klebermass-Schrehof, Ursula Felderhoff-Müser, Matthias Krause

  • Erkrankungen der Haut und der Knochen

    by Christian Gille, Christoph Bührer, Thomas M.K. Völkl, Klaus Mohnike, Ulrike Herberg, Guido Stichtenoth, André Sachse

  • Immunologie und Infektiologie

    by Michael Zemlin, Angelika Berger, Lukas Wisgrill, Hans Proquitté, Christian Gille, Christoph Bührer

  • Streptokokken-Gruppe-B-Infektionen Streptokokken-Gruppe-B-Infektion

    by Fabian Lander, Reinhard Berner, Mats Ingmar Fortmann, Christian Gille, Egbert Herting, Markus Hufnagel, Mirjam Kunze, Barbara Spellerberg